Ellen Weisberg
Harvard University(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl(2005)1,480 cited
- → Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia(2007)632 cited
- → Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412(2002)598 cited
- → Smad4 and FAST-1 in the assembly of activin-responsive factor(1997)568 cited
- → AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL(2006)476 cited
- → A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader(2017)433 cited
- → Mechanism of resistance to the ABL tyrosine kinase inhibitor STI571 in BCR/ABL–transformed hematopoietic cell lines